Alto Ingredients, Inc. to Present in the LD Micro Main Event XIX
PEKIN, Ill., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Alto Ingredients, Inc. ( NASDAQ: ALTO ) , a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the LD Micro Main Event XIX on Tuesday, October 21, ...
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ALG-000184 Oral presentation will include the full 96-week and post-treatment follow up data from the Phase 1 monotherapy study of ...
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
$25.2 million in first closing, $1.2 million in second closing and $2.8 million in third and final closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first ...
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter - Profound Medical ( NASDAQ:PROF )
TORONTO, Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Profound Medical Corp. ( NASDAQ:PROF, TSX:PRN ) ( "Profound" or the "Company" ) , a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today ...
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
To release full third quarter 2025 financial results on November 13th. conference call to follow To release full third quarter 2025 financial results on November 13th. conference call to follow ...
Relmada Therapeutics Appoints Distinguished Urologic Oncologist, Max Kates, MD, to the Clinical Advisory Board to Support Development of NDV-01
Dr. Kates' experience as chair of the landmark Phase 3 BRIDGE bladder cancer trial and dedication to patient care will be invaluable to the NDV-01 Phase 3 program ...
Will Pfizer ( PFE ) Beat Estimates Again in Its Next Earnings Report? ( Revised )
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Akero Therapeutics, Inc. ( Nasdaq: AKRO ) , a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced two upcoming oral ...
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2025 Financial Results on October 21, 2025
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2025 Financial Results on October ...
Sagimet Biosciences Announces Upcoming Presentation at AASLD-The Liver Meeting® 2025 - Sagimet Biosciences ( NASDAQ:SGMT )
SAN MATEO, Calif., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Sagimet Biosciences Inc. ( NASDAQ:SGMT ) , a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that analyses of the Phase 2b FASCINATE-2 study ...
Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting® 2025 - Akero Therapeutics ( NASDAQ:AKRO )
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Akero Therapeutics, Inc. ( NASDAQ:AKRO ) , a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced two upcoming oral ...
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - Ocular Therapeutix ( NASDAQ:OCUL )
BEDFORD, Mass., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. ( NASDAQ:OCUL, "Ocular" ) ) , an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences in October 2025.
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3
NEW YORK, Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Axsome Therapeutics, Inc. ( NASDAQ: AXSM ) , a biopharmaceutical company leading a new era in the treatment of central nervous system ( CNS ) disorders, today announced it will report its financial results for the third quarter of 2025 on Monday, ...
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3 - Axsome Therapeutics ( NASDAQ:AXSM )
NEW YORK, Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Axsome Therapeutics, Inc. ( NASDAQ:AXSM ) , a biopharmaceutical company leading a new era in the treatment of central nervous system ( CNS ) disorders, today announced it will report its financial results for the third quarter of 2025 on Monday, ...
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2025 Financial Results on October 21, 2025 - Balchem ( NASDAQ:BCPC )
MONTVALE, N.J., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Balchem Corporation ( NASDAQ:BCPC ) today announced that a conference call will be held on Tuesday, October 21, 2025, at 11:00 AM Eastern Time ( ET ) to review third quarter 2025 results.
Sanuwave Health ( SNWV ) Surges 9.1%: Is This an Indication of Further Gains?
Sanuwave Health (SNWV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
2 Diagnostics Stocks That Look All Set To Surge: Growth Metrics Spike - Fonar ( NASDAQ:FONR )
Two healthcare diagnostics stocks are seeing a big spike in their Benzinga Edge Rankings Growth scores, indicating renewed strength and fervor over the past week. In Benzinga's Edge Rankings, the Growth score is assessed based on the pace at which a company grows its revenue and earnings.
Why Is Leap Therapeutics Down 9% In Pre-Market Trading? - Leap Therapeutics ( NASDAQ:LPTX )
Leap Therapeutics Inc. ( NASDAQ:LPTX ) is trading at $0.69 in pre-market, down 9.15% on Tuesday. Check out the current price of LPTX stock here. The Cambridge, Massachusetts-based biotechnology company announced $58.88 million in cash commitments for a private investment in public equity ...
1 Reason I'm Watching Intuitive Surgical Stock in 2026
The surgical robotics pioneer could cement its leading position for years to come.
Worried About Tariffs? 2 Safe Haven Stocks to Buy on the Dip With $500
Tariffs aren't likely to weigh on growth at these companies.
Tilray Brands Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Tilray Brands ( NASDAQ:TLRY )
Tilray Brands, Inc. ( NASDAQ:TLRY ) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 9. Analysts expect the Leamington, Canada-based company to report a quarterly loss at 2 cents per share, versus a year-ago loss of 1 cent per share.
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress - Cellectis ( NASDAQ:CLLS )
NEW YORK, Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Cellectis ( the "Company" ) ( NASDAQ:CLLS ) , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that findings highlighting the strong potential of ...
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
NEW YORK, Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Cellectis ( the "Company" ) ( Euronext Growth: ALCLS - NASDAQ: CLLS ) , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that findings highlighting the ...
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
NEW YORK, Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, today announced gross revenue of US$21.9 million on Ryoncil® ( remestemcel-L-rknd ) sales for the quarter ended September 30, 2025.
Why Riot Platforms Stock Skyrocketed by Nearly 11% on Monday
One pundit tracking the company believes it has one of the best facilities among a group of its peers.
Luminus Trims Its Hefty Chemours Position
Luminus Management LLC reduced its stake in The Chemours Company ( NYSE:CC ) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC filing dated October 3, 2025.Luminus Management LLC disclosed in a Securities and Exchange ...
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today - Eli Lilly ( NYSE:LLY )
Eli Lilly ( NYSE:LLY ) has outperformed the market over the past 10 years by 13.78% on an annualized basis producing an average annual return of 26.64%. Currently, Eli Lilly has a market capitalization of $757.36 billion.
DaVita HealthCare ( DVA ) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $128.14, denoting a -2.3% move from the preceding trading day.
Why Pacific Biosciences of California ( PACB ) Outpaced the Stock Market Today
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.52, marking a +2.01% move from the previous day.
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen ( DYNE-101 ) for Myotonic Dystrophy Type 1 ( DM1 )
- Robust improvement demonstrated across diverse set of clinical measures ...
Powering Possibilities: Itron Unveils Full Conference Lineup for Itron Inspire 2025
Itron revealed its Itron Inspire 2025 speaker lineup, which includes the CEO of Gainesville Regional Utilities. The event runs Oct. 24-30 in Orlanda, FL.
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
FLORHAM PARK, N.J., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Cellectar Biosciences, Inc. ( NASDAQ:CLRB ) ( "Cellectar" or the "company" ) , a late-stage biotechnology company focused on the discovery and development of drugs for the treatment of cancer, today announced an agreement between the ...
Mosaic, Financial Service Index On CNBC's 'Final Trades' - Mosaic ( NYSE:MOS ) , iShares Bitcoin Trust ( NASDAQ:IBIT )
On CNBC's "Halftime Report Final Trades," Joseph Terranova, senior managing director, Virtus Investment Partners, picked The Mosaic Company ( NYSE:MOS ) as his final trade.
Aemetis California Ethanol Plant Drives Substantial Carbon Intensity Reduction using Praj Low-Carbon MVR System - Centuri Holdings ( NYSE:CTRI ) , Aemetis ( NASDAQ:AMTX )
CUPERTINO, Calif., Oct. 07, 2025 ( GLOBE NEWSWIRE ) -- Aemetis, Inc. ( NASDAQ:AMTX ) , a renewable natural gas and biofuels company, announced today that it is advancing decarbonization at its 65 million gallon per year ethanol plant in Keyes, California with a $30 million energy efficiency ...
Is First Trust Small Cap Growth AlphaDEX ETF ( FYC ) a Strong ETF Right Now?
Smart Beta ETF report for ...
3 Dividend Stocks to Double Up On Right Now
The time is right for buying more of these great dividend stocks.
Best Income Stocks to Buy for October 7th
MTG, PAHC and ICAGY made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 7, 2025.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SVRA
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Savara Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action ...
Cathie Wood Unloads This Rocket Stock, Pours $7M Into DoorDash-But Won't Stop Buying This Chinese Giant - Alibaba Gr Hldgs ( NYSE:BABA )
On Monday, Cathie Wood-led Ark Invest made significant trades, notably increasing its stake in DoorDash Inc. ( NASDAQ:DASH ) , Alibaba Group Holding Ltd. ( NYSE:BABA ) , while reducing its position in Brera Holdings PLC ( NASDAQ:BREA ) and Rocket Lab Corp. ( NASDAQ:RKLB ) .
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Fraud Lawsuit - UNCY - Unicycive Therapeutics ( NASDAQ:UNCY )
NEW YORK, Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. ( NASDAQ:UNCY ) between March 29, 2024 and June 27, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen ( DYNE-101 ) for Myotonic Dystrophy Type 1 ( DM1 ) - Dyne Therapeutics ( NASDAQ:DYN )
- Robust improvement demonstrated across diverse set of clinical measures - - Patient-reported outcomes support clinical meaningfulness of improvements in function and strength - - Meaningful improvements in overall disease burden reported by both patients and physicians -
Aehr Test Systems Posts Q1 Earnings, Joins SANUWAVE Health And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Aehr Test System ( NASDAQ:AEHR ) , Epsium Enterprise ( NASDAQ:EPSM )
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Tuesday. Shares of Aehr Test Systems ( NASDAQ:AEHR ) fell sharply in pre-market trading after the company reported financial results for the first quarter of fiscal 2026.
This Netflix Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Advanced Micro Devices ( NASDAQ:AMD ) , Brinker International ( NYSE:EAT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
New Strong Buy Stocks for October 7th
ALHC, STNE, EGAN, PAHC and MTG have been added to the Zacks Rank #1 (Strong Buy) List on October 7, 2025.
ASUS ProArt and GoPro Join Forces to Streamline Creator Workflows with AI
Seamless storytelling: ASUS ProArt creator-focused tools and GoPro's leading capture technology simplify the storytelling process, from content capture to sharing
ASUS ProArt and GoPro Join Forces to Streamline Creator Workflows with AI
ASUS ProArt and GoPro partner to simplify creator workflows with AI, making it easier to capture, edit, and share every adventure.
Crypto mining, treasury stocks strike gold as Bitcoin booms
Bitcoin rallied to a new all-time high of over $126,000 on Monday, lifting share prices across crypto miners and some treasury companies.
Qualigen Therapeutics ( NASDAQ: QLGN ) Announces Executives, Board of Directors Appointments and Auditor Transition
Carlsbad, CA, Oct. 06, 2025 ( GLOBE NEWSWIRE ) -- Qualigen Therapeutics, Inc. ( NASDAQ: QLGN ) ( the "Company" ) today announced a series of key leadership and governance changes aimed at strengthening its executive team, enhancing financial transparency, and supporting the Company's next phase ...
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Aehr Test System ( NASDAQ:AEHR ) , Amkor Tech ( NASDAQ:AMKR )
Shares of Telomir Pharmaceuticals Inc ( NASDAQ:TELO ) rose sharply in pre-market trading after the company released promising preclinical study results for its lead compound, Telomir-1.
AMD To Rally More Than 47%? Here Are 10 Top Analyst Forecasts For Tuesday - Autoliv ( NYSE:ALV ) , Abivax ( NASDAQ:ABVX )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo raised Smurfit Westrock Plc ( NYSE:SW ) price target from $46 to $52.
